ASSOCIATION OF DIETARY INFLAMMATORY INDEX WITH SYSTEMIC INFLAMMATION IN WELL-CONTROLLED TYPE 2 DIABETES MELLITUS
Öz
Objective: Low-grade chronic inflammation contributes to residual cardiometabolic risk in type 2 diabetes (T2DM), even among patients who achieve glycemic targets. Dietary Inflammatory Index (DII) quantifies the inflammatory potential of habitual diet; however, its association with systemic inflammatory markers in well-controlled T2DM remains unclear. This study aimed to investigate the association between DII scores and circulating inflammatory markers in adults with well-controlled T2DM.
Material and Methods: This cross-sectional study included 120 adults with T2DM and 30 healthy controls. Dietary intake was assessed using a validated 7-day food frequency questionnaire, and DII scores were calculated. Patients with T2DM were stratified into DII quartiles. Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and high-sensitive C-reactive protein (hs-CRP), along with metabolic parameters, were measured. Associations were evaluated using correlation and regression analyses, and effect sizes were estimated using Cohen’s d.
Results: DII scores were positively correlated with IL-6 (r=0.421, p<0.001) and hs–CRP (r=0.312, p=0.002). IL 6 levels increased progressively across DII quartiles (p for trend <0.001), with a large effect size between the lowest and highest quartiles (Cohen’s d=0.84). Higher DII scores were associated with lower intakes of dietary fiber, polyunsaturated fatty acids, magnesium, and vitamin C (all p<0.05). Serum uric acid levels also increased across DII quartiles (p=0.044). No significant association was observed between DII and TNF-α.
Conclusions: In adults with well-controlled T2DM, a more proinflammatory diet is associated with higher systemic inflammation, particularly elevated IL 6 levels. These findings suggest that dietary inflammatory potential may contribute to residual cardiometabolic risk beyond glycemic control.
Anahtar Kelimeler
Kaynakça
- ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2023. Diabetes Care 2023;46(Suppl_1):S19-40. google scholar
- Pradhan AD. Sex differences in the metabolic syndrome: implications for cardiovascular health in women. Clin Chem 2014;60(1):44-52. google scholar
- Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116(7):1793-801. google scholar
- Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444(7121):860-7. google scholar
- Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27(3):813-23. google scholar
- Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011;117(14):3720-32. google scholar
- Galland L. Diet and inflammation. Nutr Clin Pract 2010;25(6):634-40. google scholar
- Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011;106(S3):S5-78. google scholar
Ayrıntılar
Birincil Dil
İngilizce
Konular
Endokrinoloji
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
14 Ağustos 2026
Gönderilme Tarihi
9 Şubat 2026
Kabul Tarihi
21 Mayıs 2026
Yayımlandığı Sayı
Yıl 2026 Cilt: 89 Sayı: 3